Your browser doesn't support javascript.
loading
Antioxidant and In Vivo Hypoglycemic Activities of Ethanol Extract from the Leaves of Engelhardia roxburghiana Wall, a Comparative Study of the Extract and Astilbin.
Guo, Xiaoqiang; Zhou, Ting; Xing, Hongxia; Zhang, Yucheng; Fang, Jingmei; Kang, Tairan; Yao, Caimei; Yan, Jun; Huang, Yaxuan; Yao, Qian.
  • Guo X; School of Pharmacy, Chengdu University, Chengdu 610106, China.
  • Zhou T; School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
  • Xing H; School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
  • Zhang Y; School of Pharmacy, Chengdu University, Chengdu 610106, China.
  • Fang J; School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
  • Kang T; School of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
  • Yao C; School of Pharmacy, Chengdu University, Chengdu 610106, China.
  • Yan J; School of Pharmacy, Chengdu University, Chengdu 610106, China.
  • Huang Y; Zhanglan College, Chengdu University, Chengdu 610106, China.
  • Yao Q; School of Pharmacy, Chengdu University, Chengdu 610106, China.
Foods ; 12(5)2023 Feb 22.
Article en En | MEDLINE | ID: mdl-36900444
The leaves of Engelhardia roxburghiana Wall (LERW) has been used as sweet tea in China throughout history. In this study, the ethanol extract of LERW (E-LERW) was prepared and the compositions were identified by HPLC-MS/MS. It indicates that astilbin was the predominant component in E-LERW. In addition, E-LERW was abundant in polyphenols. Compared to astilbin, E-LERW presented much more powerful antioxidant activity. The E-LERW also had stronger affinity with α-glucosidase and exerted more vigorous inhibitory effect on the enzyme. Alloxan-induced diabetic mice had significantly elevated glucose and lipid levels. Treatment with E-LERW at the medium dose (M) of 300 mg/kg could reduce the levels of glucose, TG, TC, and LDL by 16.64%, 12.87%, 32.70%, and 22.99%, respectively. In addition, E-LERW (M) decreased food intake, water intake, and excretion by 27.29%, 36.15%, and 30.93%, respectively. Moreover, E-LERW (M) therapy increased the mouse weight and insulin secretion by 25.30% and 494.52%. With respect to the astilbin control, E-LERW was more efficient in reducing the food and drink consumption and protecting pancreatic islet and body organs from alloxan-induced damage. The study demonstrates that E-LERW may be a promising functional ingredient for the adjuvant therapy of diabetes.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article